| 000 | 01310 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250514043542.0 | ||
| 264 | 0 | _c20030606 | |
| 008 | 200306s 0 0 eng d | ||
| 022 | _a0039-128X | ||
| 024 | 7 |
_a10.1016/s0039-128x(02)00051-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDoering, Dagmar D | |
| 245 | 0 | 0 |
_aEffects of butyltins on human 5alpha-reductase type 1 and type 2 activity. _h[electronic resource] |
| 260 |
_bSteroids _cSep 2002 |
||
| 300 |
_a859-67 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a3-Oxo-5-alpha-Steroid 4-Dehydrogenase _xmetabolism |
| 650 | 0 | 4 | _a5-alpha Reductase Inhibitors |
| 650 | 0 | 4 |
_aAndrostenedione _xmetabolism |
| 650 | 0 | 4 |
_aBrain _xenzymology |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 |
_aMicrosomes _xmetabolism |
| 650 | 0 | 4 | _aOrganotin Compounds |
| 650 | 0 | 4 |
_aProtein Isoforms _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aTrialkyltin Compounds _xpharmacology |
| 700 | 1 | _aSteckelbroeck, Stephan | |
| 700 | 1 | _aDoering, Thomas | |
| 700 | 1 | _aKlingmüller, Dietrich | |
| 773 | 0 |
_tSteroids _gvol. 67 _gno. 10 _gp. 859-67 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0039-128x(02)00051-x _zAvailable from publisher's website |
| 999 |
_c12110660 _d12110660 |
||